Features | Partner Sites | Information | LinkXpress
Sign In
PZ HTL SA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Compact Ultralow Temperature Storage Solutions Available

By BiotechDaily International staff writers
Posted on 01 Jun 2014
Image: The Hamilton BIOS M Ultra-low Temperature Storage System (Photo courtesy of Hamilton Storage Technologies).
Image: The Hamilton BIOS M Ultra-low Temperature Storage System (Photo courtesy of Hamilton Storage Technologies).
A line of advanced deep freezers with robotic sample access is now available for biotech and life science laboratories.

The Hamilton Storage Technologies (Franklin, MA, USA) BiOS M and L are two compact high-density systems for the ultralow-temperature storage of sensitive biological samples.

All samples within the BiOS systems are stored in -80 degrees Celsius chest freezer compartments to maintain temperature stability. All internal workflows, including sample picking, are optimized to keep samples at ultralow temperatures at all times. System parts are easily accessible for service and maintenance, while one-dimensional and two-dimensional barcode reading and sample tracking provide complete chain-of-custody documentation—a requirement for forensic laboratories. Multiple backup systems ensure that samples stay at -80 degrees Celsius in the event of power failure.

“By adding smaller configurations of our high-capacity BiOS -80 degree Celsius storage system, more labs have access to state-of-the-art sample storage within steps of their sample preparation and analysis stations,” said Dr. Martin Frey, PhD, head of Hamilton Storage Technologies. “This reduces the likelihood that results may be compromised.”

Related Links:
Hamilton Storage Technologies



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: Disruption and removal of malaria parasites by the experimental drug (+)-SJ733 (Photo courtesy of the University of California, San Francisco).

Experimental Antimalaria Drug Induces the Immune System to Destroy Infected Red Blood Cells

An experimental drug for the treatment of malaria was found to induce morphological changes in infected erythrocytes that enabled the immune system to recognize and eliminate them. Investigators at... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.